Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?

doi:10.3748/wjg.v25.i5.622

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8267)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

529

WORD

329

HTML

3962

Figures (1-3)

400

Tables (1-3)

287

Sum=5507

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1177

Download

1583

Sum=2760

Feb 7, 2019 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Feb 7, 2019; 25(5): 622-631
Published online Feb 7, 2019. doi: 10.3748/wjg.v25.i5.622

Full Size Figure Download Figure

Figure 3 Pathologically confirmed intrahepatic cholangiocarcinoma in a 47-year-old man. A: A 53.2-mm hypointense mass is seen on the precontrast image; B: The image shows rim-like hyperenhancement in the arterial phase; C: Peripheral “washout” in the portal venous phase; D: Targetoid appearance in the hepatobiliary phase; and E: Target sign in diffusion-weighted imaging; F: The mass was confirmed as intrahepatic cholangiocarcinoma at 200 × magnification after hematoxylin-eosin staining.

Citation: Zhang T, Huang ZX, Wei Y, Jiang HY, Chen J, Liu XJ, Cao LK, Duan T, He XP, Xia CC, Song B. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy? World J Gastroenterol 2019; 25(5): 622-631
URL: https://www.wjgnet.com/1007-9327/full/v25/i5/622.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i5.622